References
- Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. Circulation 1979;59:8-13. https://doi.org/10.1161/01.CIR.59.1.8
- Ha JK, Han DC, Hwang KW, et al. Metabolic syndrome and risk of in-stent restenosis: clinical outcomes in patients undergoing percutaneous coronary intervention. Korean Circ J 2007;37:567-73. https://doi.org/10.4070/kcj.2007.37.11.567
- Park JS, Seok JH, Hong GR, Shin DG, Kim YJ, Shim BS. Types of in-stent restenosis and predictive factors for diffuse type in-stent restenosis. Korean Circ J 2001;31:1135-41. https://doi.org/10.4070/kcj.2001.31.11.1135
- Nielsen TT, Botker HE. Percutaneous coronary intervention in diabetic patients: a problem? Horm Metab Res 2005;37(Suppl 1):83-9. https://doi.org/10.1055/s-2005-861378
- Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95. https://doi.org/10.1056/NEJM199408253310801
- Vaitkevicius PV, Lane M, Spurgeon H, et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A 2001;98:1171-5. https://doi.org/10.1073/pnas.98.3.1171
- Candido R, Forbes JM, Thomas MC, et al. A breaker of advanced glycation end products attenuates diabetes induced myocardial structural changes. Circ Res 2003;92:785-92. https://doi.org/10.1161/01.RES.0000065620.39919.20
- Little WC, Zile MR, Kitzman DW, Hundley WG, O'Brien TX, Degroof RC. The effect of alagebrium chloride(ALT-711), a novel glucose cross link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 2005;11:191-5. https://doi.org/10.1016/j.cardfail.2004.09.010
- Cooper ME. Impotance of advanced glycation end products in diabetes associated cardiovascular and renal disease. Am J Hypertens 2004;17:31S-8S. https://doi.org/10.1016/j.amjhyper.2004.08.021
- Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003;93:1159-69. https://doi.org/10.1161/01.RES.0000103862.26506.3D
- Kass DA, Shapiro EP, Kaawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end product crosslink breakers. Circulation 2001;104:1464-70. https://doi.org/10.1161/hc3801.097806
- Wolffenbulttel BH, Boulanger CM, Crijns FR, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A 1998;95:4630-4. https://doi.org/10.1073/pnas.95.8.4630
- Ettenson DS, Gotlieb AI. Centrosomes, microtubules, and microfilaments in the reendothelialization and remodeling of double-sided in vitro wound. Lab Invest 1992;66:722-33.
- Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 1994;93:1243-9. https://doi.org/10.1172/JCI117078
- Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury: I. smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-33.
- Sakaguchi T, Yan SF, Yan SD, et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003;111:959-72. https://doi.org/10.1172/JCI17115
- Naka Y, Bucciarelli LG, Wendt T, et al. RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 2004;24:1342-9. https://doi.org/10.1161/01.ATV.0000133191.71196.90
- Shim CY, Park S, Yoon SJ, et al. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population. Cardiology 2007;107:261-8. https://doi.org/10.1159/000095516
- Susic D, Varagic J, Ahn J, Frohlich ED. Crosslink breakers: a new approach to cardiovascular therapy. Curr Opin Cardiol 2004;19:336-40. https://doi.org/10.1097/01.hco.0000127135.73849.4f
- Forbes JM, Yee LT, Thallas V, et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 2004;53:1813-23. https://doi.org/10.2337/diabetes.53.7.1813
- Zhuo Z, Wang K, Penn MS, et al. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003;107:2238-43. https://doi.org/10.1161/01.CIR.0000063577.32819.23
- Yue TL, Bao W, Gu JL, et al. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury. Diabetes 2005;54:554-62. https://doi.org/10.2337/diabetes.54.2.554
- Park S, Lim S, Chang W, et al. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway. Yonsei Med J 2008;49:592-600. https://doi.org/10.3349/ymj.2008.49.4.592
Cited by
- Potential Clinical Utility of Advanced Glycation End Product Cross-Link Breakers in Age- and Diabetes-Associated Disorders vol.15, pp.6, 2010, https://doi.org/10.1089/rej.2012.1335
- The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome vol.38, pp.10, 2010, https://doi.org/10.1007/s00134-012-2624-y
- Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats vol.2015, pp.None, 2010, https://doi.org/10.1155/2015/346259
- Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats vol.39, pp.6, 2010, https://doi.org/10.3109/01913123.2015.1045664
- Targeting advanced glycation with pharmaceutical agents: where are we now? vol.33, pp.4, 2016, https://doi.org/10.1007/s10719-016-9691-1
- The arterial microenvironment: the where and why of atherosclerosis vol.473, pp.10, 2010, https://doi.org/10.1042/bj20150844
- Effect of Advanced Glycation End‐Products (AGE) Lowering Drug ALT‐711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD‐MBD vol.35, pp.3, 2010, https://doi.org/10.1002/jbmr.3925
- LIMITED JOINT MOBILITY IN A CHILD WITH TYPE 1 DIABETES MELLITUS. vol.2021, pp.None, 2010, https://doi.org/10.1155/2021/6397338